Actively Recruiting

Phase Not Applicable
Age: 16Years - 65Years
All Genders
ID07129954

Fear of Falling in Muscular Dystrophy: Investigation of the Phenomenon and a Multidisciplinary Rehabilitation Approach to Treat It

Led by Universita di Verona · Updated on 2025-08-19

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the fear of falling (FOF) in people with muscular dystrophy, including types like myotonic, facio-scapular-humeral, Becker, cingulate, Emery-Dreifuss, and distal dystrophies. The study aims to understand how common FOF is in this group, how it changes over time, and how clinical, motor, cognitive, and psychological factors relate to FOF. It also evaluates two treatment approaches for those with disabling FOF: motor rehabilitation alone versus motor rehabilitation combined with cognitive-behavioral therapy. The study includes two treatment groups. One group receives motor rehabilitation sessions lasting 45 minutes each, with a total of 36 sessions focused on joint mobility, balance, gait training, proprioception, and use of special rehabilitation devices. The other group receives the same motor rehabilitation but fewer sessions (24 total) combined with weekly 45-minute cognitive-behavioral therapy (CBT) sessions over 12 weeks. CBT sessions work on identifying and changing thoughts and behaviors related to fear of falling. Participants will be assessed using various tools at baseline and multiple follow-up points up to nine months. The primary measure is the Falls Efficacy Scale-International (FES-I) to assess fear of falling. Secondary assessments include physical function tests, cognitive and psychological evaluations, walking activity monitored by pedometer, and quality of life surveys. The study will monitor how treatments affect fall frequency, cognitive and emotional health, and overall function.

CONDITIONS

Brief Title

Fear of Falling in Muscular Dystrophy

Who Can Participate

Age: 16Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of muscular dystrophy: myotonic, facio-scapular-humeral, Becker, cingulate, Emery-Dreifuss, or distal
  • Age between 16 and 65 years
  • Residual walking ability with a functional ambulation category of at least 1
  • Mini-Mental State Examination (MMSE) score corrected for age and education of at least 23.8 points
  • For Work Package 2: persistent fear of falling at 3 months with a Falls Efficacy Scale-International (FES-I) score of 16 or higher
Not Eligible

You will not qualify if you...

  • Factors that make it impossible to ensure proper adherence to treatment
  • Participation in other rehabilitation programs or research studies
  • Language barriers preventing study participation
  • Failure to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 12 weeks

Participants receive motor rehabilitation sessions focusing on joint range maintenance, balance, gait training, proprioception, and scenic reinforcement. Some participants also receive additional cognitive behavioral therapy sessions targeting cognition, emotions, and behaviors related to fear of falling.

Multiple sessions per week totaling 36 sessions over 12 weeks

Follow-up

Duration - Up to 9 months post-baseline

Participants are assessed at multiple time points after treatment to evaluate physical and cognitive outcomes related to fear of falling and muscular dystrophy.

Assessments at 3, 6, and 9 months after baseline

Trial Site Locations

Total: 1 location

1

Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione

Verona, verona, Italy, 37134

Actively Recruiting

Loading map...

Research Team

V

Valentina Varalta, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study...

Duchenne Muscular Dystrophy (DMD)

Actively Recruiting

14 locations

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study...

Duchenne Muscular Dystrophy (DMD)

Actively Recruiting

15 locations

A Suggested Rehabilitation Protocol for the Treatment of C-s...

Idiopathic Scoliosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here